anti-MAP/microtubule Affinity-Regulating Kinase 4 (MARK4) Antibodies

Human MAP/microtubule Affinity-Regulating Kinase 4 (MARK4) interaction partners

1. data demonstrate that miR-515-5p dramatically inhibits cell migration by directly down-regulating MARK4 expression in two different cancer types

2. Our results show that MARK4 acts as a negative regulator of the Hippo kinase cassette to promote YAP/TAZ activity and that loss of MARK4 restrains the tumorigenic properties of breast cancer cells.

3. Atypical PKC phosphorylates serine-threonine residues of MARK4.

4. Suggest role for polypyrimidine-tract binding protein in regulating alternative splicing of MARK4 in gliomas.

5. MARK4 is a key component in the regulation of microtubule dynamics and has major role in cell cycle progression, particularly at the G1/S transition.

6. Molecular dynamic simulation data predicted the three dimensional structure for the kinase domain of MARK4 and its structural properties.

7. A strong and significant elevation of MARK4 expression and MARK4-tau interactions in AD brains correlates with the Braak stages of the disease, suggesting that the MARK4-tau interactions are of functional importance in the progression of AD.

8. MARK4 is a critical positive regulator of early steps in ciliogenesis.

9. MARK4 is a new negative regulator of mTORC1

10. The balance between the MARK4 isoforms is carefully guarded during neural differentiation but may be subverted in gliomagenesis.

11. Even though an association of the polymorphisms rs2850328 and rs2395 and breast cancer was not detected in our case-control study population, other variants within the PPP3CA and MARK4 genes may still be associated with breast cancer.

12. demonstrated that the endogenous MARK4L colocalizes with centrosomes at all mitotic stages and resides in centrosome-enriched fractions.

13. Normally expressed in neural progenitors, re-expressed in gliomas and may become a target of amplification upon chr. 19 rearrangement.

14. MARK4 is likely to be directly involved in microtubule organization in neuronal cells

15. NUAK1 and MARK4 are substrates of USP9X

Mouse (Murine) MAP/microtubule Affinity-Regulating Kinase 4 (MARK4) interaction partners

1. Inflammasome stimuli can act as polarizing cues to initiate dynamic NLRP3 and MARK4 transport in macrophages.

2. PPARgamma interacted with Mark4 and inhibited the stimulating effect of Mark4 on oxidative stress and inflammation.

3. MARK4 is a critical positive regulator of early steps in ciliogenesis.

4. data indicate a key role of MARK4 in energy metabolism, implicating the kinase as a novel drug target for the treatment of obesity and type 2 diabetes.

5. The balance between the MARK4 isoforms is carefully guarded during neural differentiation but may be subverted in gliomagenesis.

6. MARK4 is a functional protein kinase which specifically phosphorylates a cognate peptide substrate for the AMP-kinase family. On overexpression in heterologous cells functional wild-type protein, but not its kinase-dead mutant, decreased cell viability